<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJMPCERO</journal-id><journal-title-group><journal-title>International Journal of Medical Physics, Clinical Engineering and Radiation Oncology</journal-title></journal-title-group><issn pub-type="epub">2168-5436</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijmpcero.2014.33019</article-id><article-id pub-id-type="publisher-id">IJMPCERO-48142</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject></subj-group></article-categories><title-group><article-title>
 
 
  Carbon-Ion Beams Efficiently Induce Cell Killing in X-Ray Resistant Human Squamous Tongue Cancer Cells
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>kihisa</surname><given-names>Takahashi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hongyu</surname><given-names>Ma</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Akiko</surname><given-names>Nakagawa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yukari</surname><given-names>Yoshida</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tatsuaki</surname><given-names>Kanai</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tatsuya</surname><given-names>Ohno</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yoshikazu</surname><given-names>Kuwahara</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Manabu</surname><given-names>Fukumoto</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Takashi</surname><given-names>Nakano</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Gunma University Heavy Ion Medical Center, Gunma, Japan</addr-line></aff><aff id="aff1"><addr-line>Advanced Scientific Research Leaders Development Unit, Gunma University, Gunma, Japan</addr-line></aff><aff id="aff4"><addr-line>Department of Pathology, IDAC, Tohoku University, Sendai, Japan</addr-line></aff><aff id="aff2"><addr-line>Department of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma, Japan</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>a-takahashi@gunma-u.ac.jp(KT)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>06</month><year>2014</year></pub-date><volume>03</volume><issue>03</issue><fpage>133</fpage><lpage>142</lpage><history><date date-type="received"><day>22</day>	<month>May</month>	<year>2014</year></date><date date-type="rev-recd"><day>21</day>	<month>June</month>	<year>2014</year>	</date><date date-type="accepted"><day>21</day>	<month>July</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   In order to see whether carbon ion (C-ion) beams have a biological advantage over X-rays, studies were designed to examine the effects of C-ion beams on radiosensitivity in X-ray resistant cells. Clinically relevant X-ray resistant SAS-R cells derived from human tongue cancer SAS cells were used. The cells were exposed to X-rays or Spread-Out Bragg peak (SOBP) beam C-ions. Cell survival was measured using a modified high-density survival assay. Cell survival signaling and cell death signaling were analyzed using flow cytometry. The cells were labeled with putative cancer stem cell markers such as CD44 and CD326. SAS-R cells were 1.6 times more radioresistant than SAS cells after exposure to X-rays. Cell survival was similar in each cell line after exposure to C-ion beams. SAS-R cells displayed enhanced cell survival signaling when compared to SAS cells under normal conditions. On the other hand, the phosphorylation of AKT-related proteins decreased and polycaspase activities were enhanced when cells were irradiated with C-ion beams in both cell lines. More CD44 and CD326 positive cells were seen in SAS-R cells than in SAS cells. Moreover, the marker positive cell numbers significantly decreased after exposure to C-ion beams when compared to X-rays at iso-survival doses in SAS-R cells. C-ion beams efficiently induced cell killing in X-ray resistant cells which displayed activated cell survival signaling and contained more numerous cancer stem-like cells.  
 
</p></abstract><kwd-group><kwd>Carbon-Ion Beams</kwd><kwd> X-Ray Resistant Cells</kwd><kwd> Cell Survival and Death Signaling</kwd><kwd> Cancer Stem-Like Cells</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Radiotherapy (RT) is one of the major therapeutic modalities for eradicating malignant tumors. RT is a good al- ternative to surgery for long-term control of many tumors of the head and neck, lung, cervix, bladder, prostate and skin, where it often achieves a reasonable probability of tumor control [<xref ref-type="bibr" rid="scirp.48142-ref1">1</xref>] . Standard conventional RT for tumor treatment consists of daily exposures to a fractionated dose of around 2 Gy for 5 - 7 weeks. Although tu- mors receive a large total dose through multiple fractionated radiation exposures (FR), they sometimes recur with radioresistance [<xref ref-type="bibr" rid="scirp.48142-ref2">2</xref>] . The existence of radioresistant cells remains one of the most critical obstacles for RT. Therefore, we have defined “clinically relevant radioresistant (CRR) cells” as cells which continue to grow, even after exposure to 2 Gy/day of X-rays for more than 30 days in vitro [<xref ref-type="bibr" rid="scirp.48142-ref3">3</xref>] . In order to understand the mechan- isms involved in cellular radioresistance and to develop more effective radiotherapy, we have established CRR cell lines [<xref ref-type="bibr" rid="scirp.48142-ref3">3</xref>] -[<xref ref-type="bibr" rid="scirp.48142-ref9">9</xref>] . It was shown that the CRR cells acquired radioresistance through the activation of the serine/ threonine protein kinase B (PKB, also known as AKT) survival signaling pathway [<xref ref-type="bibr" rid="scirp.48142-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.48142-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.48142-ref8">8</xref>] . This pathway controls cellular “on-off switches” related to apoptosis and autophagy which are induced by radiation [<xref ref-type="bibr" rid="scirp.48142-ref10">10</xref>] . Au- tophagy is a programmed cell death mode like apoptosis, but is different from other cell death modes because of the presence of autophagosomes, autolysosomes and an intact nucleus in the cell [<xref ref-type="bibr" rid="scirp.48142-ref11">11</xref>] . In addition, the activation of AKT-related signaling was reported to enhance cancer stem cell (CSC) phenotypes [<xref ref-type="bibr" rid="scirp.48142-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.48142-ref12">12</xref>] . The CSC theory hypothesizes that tumors contain heterogeneous cell populations and that tumor growth is driven by a discrete subpopulation of CSCs which are defined by their capacity for self-renewal and by their ability to generate he- terogeneous lineages of cancer cells [<xref ref-type="bibr" rid="scirp.48142-ref13">13</xref>] . These CSCs can provide a reservoir of cells which can lead to tumor recurrence, even after RT, through the presence of efficient DNA repair machinery and a resistance to apoptosis [<xref ref-type="bibr" rid="scirp.48142-ref14">14</xref>] -[<xref ref-type="bibr" rid="scirp.48142-ref16">16</xref>] . Thus, a cell’s fate might be determined by a balance between cell survival and death after irradiation through AKT survival signaling.</p><p>Heavy charged particle RT using carbon ions (C-ions) is a newly emerging and promising therapy which can offer several advantages over conventional RT. C-ion beams have an excellent dose distribution for treating ma- lignant tumors [<xref ref-type="bibr" rid="scirp.48142-ref17">17</xref>] . Clinical studies performed on various cancers have provided evidence that local control and survival rates for C-ion RT are higher than that for conventional RT [<xref ref-type="bibr" rid="scirp.48142-ref18">18</xref>] -[<xref ref-type="bibr" rid="scirp.48142-ref20">20</xref>] . Recently, we demonstrated that charged particle radiation depresses AKT-related survival signaling [<xref ref-type="bibr" rid="scirp.48142-ref21">21</xref>] . Therefore, we speculated that C-ion beams may enhance apoptosis and/or autophagy, and may target CSCs via the depression of AKT survival sig- naling in X-ray resistant cancer cells.</p><p>In this paper, to more clearly define the effect of C-ion beams on radiosensitivity, mode of cell death, cell signaling and the population of CSCs, X-ray resistant tumor cells were used which were capable of proliferation when subjected to daily X-ray exposures.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Cell Lines</title><p>The cell lines used in these studies were human SAS head and neck squamous carcinoma cells (HNSCC) ob- tained from the Cell Resource Center for Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University. SAS-R cells were derived from SAS cells grown under daily exposures to 2 Gy of X-rays [<xref ref-type="bibr" rid="scirp.48142-ref4">4</xref>] (total irradiation dose: 2278 Gy). Cryo-preserved cells were used after 1 week of growth in culture without ir- radiation. Cells were cultured in DMEM-10 (Dulbecco’s modified Eagle’s medium) containing 10% (v/v) fetal bovine serum, 20 mM 2-[4-(2-hydroxyethyl)-1-piperazinyl] ethanesulfonic acid, penicillin (50 units/ml) and streptomycin (50 μg/ml). Cells were cultured at 37˚C in a conventional humidified CO<sub>2</sub> incubator.</p></sec><sec id="s2_2"><title>2.2. Irradiation</title><p>Exponentially growing cells were irradiated at room temperature with X-rays and C-ion beams. X-irradiation was delivered by a 200-kVp X-ray generator (TITAN-225S, Shimadzu, Kyoto, Japan) with a total filtration of 0.5 mm aluminum plus 0.5-mm copper. The X-ray dose rate was about 1.3 Gy/min which was measured using a thimble ionization chamber (PTW FREIBURG, Freiburg, Germany) at the sample position. C-ion beam irradia- tion (290 MeV/nucleon, 6-cm spread-out Bragg peak (SOBP): 50 keV/μm) [<xref ref-type="bibr" rid="scirp.48142-ref17">17</xref>] was performed in the Gunma University Heavy Ion Medical Center (GHMC, Gunma, Japan) [<xref ref-type="bibr" rid="scirp.48142-ref22">22</xref>] . Each irradiation was performed through a 3.5 mm layer of culture medium and a 1 mm plastic cover in a Nunc<sup>TM</sup> flask or multidish (Thermo Fisher Scien- tific, Waltham, MA).</p></sec><sec id="s2_3"><title>2.3. Modified High-Density Survival Assay</title><p>Cell survival was determined with the modified high-density survival (HDS) assay [<xref ref-type="bibr" rid="scirp.48142-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.48142-ref23">23</xref>] . Briefly, 4 &#215; 10<sup>4</sup> ex- ponentially growing cells were seeded into a φ15 mm Nunc<sup>TM</sup> multidish (Thermo Fisher Scientific). After a 24 h incubation, cells were exposed to various doses of X-rays or C-ion beams and incubated for another 72 h. Sub- sequently, cells from each flask were seeded into another 25 cm<sup>2</sup> flask and incubated for further 72 h. The total number of cells in each flask was then counted using the trypan blue dye exclusion test using a TC10<sup>TM</sup> auto- mated cell counter (BIO-RAD, Hercules, CA). Cell survival was plotted and the relative biological effectiveness (RBE) value of C-ion beams was compared to X-rays at a 20% survival dose (D<sub>20</sub>).</p></sec><sec id="s2_4"><title>2.4. Analysis of Nuclear Size</title><p>Attached and floating cells were collected using trypsin at 72 h after irradiation. The cells were fixed with 1% glutaraldehyde in PBS at 4˚C, washed with PBS, stained with 0.2 mM Hoechst 33342 (Nacalai Tesque, Kyoto, Japan), and then observed under a BZ-9000 fluorescent microscope (Keyence, Tokyo, Japan). The nucleus size in the cells was analyzed using the Duolink<sup>&#174;</sup> ImageTool (Olink Bioscience, Uppsala, Sweden). Cells with a nucleus with an area of less than 10 μm<sup>2</sup> were considered pyknotic. Cells with a nucleus with an area of over 50 μm<sup>2</sup> were considered as polyploid. A minimum of 500 cells was counted in every sample, and the percentage of pyknotic and polyploid cells was recorded.</p></sec><sec id="s2_5"><title>2.5. Analysis of Autophagy</title><p>At 72 h after irradiation, the cells were stained with a Cyto-ID<sup>&#174;</sup> Autophagy Detection kit (Enzo Life Sciences, Farmingdale, NY). The frequency of Cyto-ID<sup>&#174;</sup> green stained autophagic vacuoles was measured using a flow cytometer (FACSCalibur<sup>TM</sup>, Becton Dickinson, San Jose, CA).</p></sec><sec id="s2_6"><title>2.6. Cell Survival Signaling Assay</title><p>At 3 h after irradiation, cells were stained with a FlowCellect<sup>TM</sup> PI3K-mTOR Signaling Cascade Mapping Kit (Merck Millipore, Darmstadt, Germany). The phosphorylation of AKT (Ser473) and ribosomal protein S6 (rps6) (Ser235) proteins was measured using a flow cytometer.</p></sec><sec id="s2_7"><title>2.7. Cell Death Signaling Assay</title><p>At 72 h after irradiation, cells were stained with a Vybrant<sup>&#174;</sup> FAM<sup>TM</sup> Poly Caspase Assay Kit (Invitrogen<sup>TM</sup>, Thermo Fisher Scientific). The activation of pan-caspase was measured using a flow cytometer.</p></sec><sec id="s2_8"><title>2.8. Analysis of Cancer Stem-Like Cells</title><p>CSCs are typically recognized by virtue of their expression of cell surface markers such as CD44 and CD326 (EpCAM) in HNSCC [<xref ref-type="bibr" rid="scirp.48142-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.48142-ref25">25</xref>] . At 72 h after irradiation, the cells were labeled with putative CSC markers, hu- man monoclonal CD44 antibodies conjugated to fluorescein isothiocyanate (FITC) (Miltenyi Biotec K. K., Ber- gisch Gladbach, Germany) and human monoclonal CD326 antibodies conjugated to phycoerythrin (PE) (Mil- tenyi Biotec). The frequency of CD44 and CD326 positive cells was measured using a flow cytometer.</p></sec><sec id="s2_9"><title>2.9. Statistics</title><p>The data from three independent experiments were expressed as mean values with standard deviations. The sta- tistical significance was tested with the Student’s t-test. A p value of &lt;0.05 was considered to be statistically significant.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. C-Ion Beams Efficiently Induced Cell Killing in X-Ray-Resistant Cells</title><p>The D<sub>20</sub> dose of X-rays was 7.5 Gy and 12.0 Gy in SAS cells and SAS-R cells, respectively. The D<sub>20</sub> dose of C-ion beams was 3.0 Gy and 3.2 Gy in SAS cells and SAS-R cells, respectively. After exposure to X-rays, SAS-R cells were found to be 1.6 times more radioresistant than SAS cells, although the cell survival rate was similar in each cell line after exposure to C-ion beams (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The RBE at a D<sub>20</sub> dose in SAS cells and SAS-R cells was 3.8 and 2.5, respectively.</p><p>Changes in nuclear size were analyzed using Hoechst 33342 staining at 72 h after irradiation (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Fig- ure 2(c) and <xref ref-type="fig" rid="fig2">Figure 2</xref>(d) show X-ray and C-ion beam induced pyknotic and polyploid cells appearing in a</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Cell survival measured with the modified high-density survival assay. Open symbols, SAS cells; closed symbols, SAS-R cells. Circles, X-rays; triangles, C-ion beams</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/3-2660082x6.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Changes in nuclear size at 72 h after irradiation in SAS and SAS-R cells. Note that the labels on the bottom of the figure below panel (d) apply to all of the panels (b), (c), and (d). (a) Photograph (400&#215;) using Hoechst 33342 staining in unirradiated and irradiated SAS-R cells; (b) Chart showing nuclear sizes in SAS-R cells; (c) The frequency of pyknosis; (d) The frequency of polyploid cells. Error bars indicate stand- ard deviations. Data were statistically evaluated with the Student’s t-test between unirradiated cells and irradiated cells, and between the samples connected with a fine line (<sup>*</sup>p &lt; 0.05, <sup>*</sup><sup>*</sup>p &lt; 0.01, and <sup>***</sup>p &lt; 0.001)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/3-2660082x7.png"/></fig><p>dose-dependent manner in SAS cells and SAS-R cells. At the iso-doses, the frequency of hyperinduced pyknosis was greater in C-ion irradiated cells than in X-irradiated cells. At the iso-survival doses obtained from the HDS assay, although no significant differences in the induction of pyknosis were observed in either cell line (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c)), C-ion beams suppressed the appearance of polyploid cells (<xref ref-type="fig" rid="fig2">Figure 2</xref>(d)).</p><p>The basal level of Cyto-ID<sup>&#174;</sup> green positive-stained autophagic vacuoles was detected at high levels in SASR cells when compared to SAS cells (<xref ref-type="fig" rid="fig3">Figure 3</xref>(c)). At iso-doses, C-ion beams induced autophagy when com- pared to X-rays in both cell lines. Even at iso-survival doses, the C-ion beams induced notably higher levels of autophagy when compared to X-rays in SAS-R cells.</p></sec><sec id="s3_2"><title>3.2. C-Ion Beams Suppressed Cell Survival Signaling and Induced Cell Death Signaling in X-Ray Resistant Cells</title><p>The activation of poly-caspase leading to cell death signaling was analyzed at 72 h after irradiation (<xref ref-type="fig" rid="fig4">Figure 4</xref>(a)). X-rays and C-ion beams induced the activation of poly-caspase in a dose-dependent manner in SAS-R cells. At iso-survival doses, activation was greater in C-ion irradiated cells than in X-irradiated cells.</p><p>The expression of phospho-AKT (p-AKT) and phospho-rpS6 (p-rpS6) cell survival signals was analyzed at 3 h after irradiation (<xref ref-type="fig" rid="fig4">Figure 4</xref>(b) and <xref ref-type="fig" rid="fig4">Figure 4</xref>(c)). The expression of both p-AKT and p-rpS6 was highly acti- vated in SAS-R cells when compared to SAS cells in non-irradiated cells. X-rays and C-ion beams suppressed the expression in a dose-dependent manner in SAS-R cells. Not only at the iso-doses but also at D<sub>50</sub> and D<sub>20</sub> iso-survival doses, their expression was suppressed more efficiently in C-ion irradiated cells than in X-irradiated cells.</p></sec><sec id="s3_3"><title>3.3. Cancer Stem-Like Cell Numbers Decreased Significantly after Exposure to C-Ion Beams</title><p>Cells were labeled with the putative CSC markers CD44 and CD326. Basal levels of double labeled positive</p><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Stained autophagic vacuoles at 72 h after irradiation in SAS and SAS-R cells. (a) Photograph (400&#215;) using phase contrast and fluorescent microscopy in 3.2 Gy C-ion irradiated SAS-R cells. Autophagy is indicated by the heavily stained au- tophagic vacuoles (arrow) and in normal cells (arrow heads); (b) Graph showing num- bers of Cyto-ID<sup>&#174;</sup> green stained cells; (c) The frequency of autophagy. AU, arbitrary unit. Error bars indicate standard deviations. Data were statistically evaluated with the Student’s t-test between unirradiated cells and irradiated cells, and between the samples connected with the lines (<sup>*</sup>p &lt; 0.05, <sup>**</sup>p &lt; 0.01, and <sup>***</sup>p &lt; 0.001)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/3-2660082x8.png"/></fig><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Cell death signaling and cell survival signaling at 72 h (a) and 3 h (b) and (c) after irradiation of SAS-R cells. The right panels show the relative values of poly-caspase activation (a), p-AKT expression (b) and p-rps6 ex- pression (c) using the value in untreated SAS-R cells as a standard value of 100. The left panels show typical graphs illustrating the number of stained cells in each group. Note that the labels below panel (c) apply to all of the panels, (a), (b), and (c). The error bars indicate standard deviations. Data were statistically evaluated with the Student’s t-test between unirradiated cells and irradiated cells, and between the samples connected with the lines (<sup>*</sup>p &lt; 0.05, <sup>**</sup>p &lt; 0.01, and <sup>***</sup>p &lt; 0.001)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/3-2660082x9.png"/></fig><p>cells were higher in non-irradiated SAS-R cells compared to SAS cells (<xref ref-type="fig" rid="fig5">Figure 5</xref>). The number of double posi- tive cells increased in a dose-dependent manner after exposure to X-rays and C-ion beams. At the D<sub>50</sub> and D<sub>20</sub> iso-survival doses, the number of double positive cells showed a significantly larger decrease after exposure to C-ion beams than to X-rays.</p></sec></sec><sec id="s4"><title>4. Discussions</title><p>The biological advantages of using C-ion beams were a higher RBE [<xref ref-type="bibr" rid="scirp.48142-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.48142-ref27">27</xref>] , a decreased oxygen enhancement ratio [<xref ref-type="bibr" rid="scirp.48142-ref28">28</xref>] , a diminished capacity for DNA repair of cellular radiation injuries [<xref ref-type="bibr" rid="scirp.48142-ref29">29</xref>] , and the potential suppression of metastases [<xref ref-type="bibr" rid="scirp.48142-ref30">30</xref>] .</p><p>This study clearly demonstrated that C-ion beams efficiently induced cell killing in X-ray-resistant cells (<xref ref-type="fig" rid="fig1">Figure 1</xref>). These findings agree with previous results published by our group [<xref ref-type="bibr" rid="scirp.48142-ref31">31</xref>] -[<xref ref-type="bibr" rid="scirp.48142-ref33">33</xref>] which demonstrated that the RBE of heavy-ion beams in X-ray resistant p53-dysfunctional cells was higher than in X-ray sensitive wild-type p53 cells. Apoptosis was induced more efficiently when cells were exposed to heavy-ion beams than to X-rays, regardless of p53 gene status [<xref ref-type="bibr" rid="scirp.48142-ref31">31</xref>] -[<xref ref-type="bibr" rid="scirp.48142-ref33">33</xref>] . In SAS and SAS-R cells, although the contribution of apopto- sis to cellular radiosensitivity is lower than previously thought [<xref ref-type="bibr" rid="scirp.48142-ref6">6</xref>] , hyperinduced pyknosis was detected and was greater in C-ion irradiated cells than in X-irradiated cells at iso-doses (<xref ref-type="fig" rid="fig2">Figure 2</xref>(c)). Pyknosis is the irreversible condensation of chromatin in the nucleus of a cell undergoing apoptosis [<xref ref-type="bibr" rid="scirp.48142-ref11">11</xref>] . On the other hand, polyploid cells were present at lower levels in C-ion irradiated cells than in X-ray irradiated cells at iso-survival doses (<xref ref-type="fig" rid="fig2">Figure 2</xref>(d)). Radiation-induced polyploid cells usually suffer cell death from mitotic catastrophe [<xref ref-type="bibr" rid="scirp.48142-ref34">34</xref>] . Mitotic catas- trophe has been described in which mitotic failure is sensed and the cell responds by following a pathway to cell</p><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig5">Figure 5</xref></label><caption><title> The frequency of CD44 and CD326 posi- tive non-irradiated cells and in irradiated cells at 72 h after irradiation in SAS-R cells. Error bars indi- cate standard deviations. Data were statistically eva- luated with the Student’s t-test between unirradiat- ed cells and irradiated cells, and between the sam- ples connected with the lines (<sup>*</sup>p &lt; 0.05, <sup>**</sup>p &lt; 0.01, and <sup>***</sup>p &lt; 0.001)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/3-2660082x10.png"/></fig><p>death through apoptosis, necrosis, or senescence [<xref ref-type="bibr" rid="scirp.48142-ref35">35</xref>] . Autophagy has a bi-directional effect comparable to the two edges of a sword and the results can be cell death or cell survival [<xref ref-type="bibr" rid="scirp.48142-ref36">36</xref>] . Consistent with this concept, High basal levels of autophagy were detected in X-ray resistant SAS-R cells when compared to SAS cells here (Fig- ure 3(c)) as well as in a previous report [<xref ref-type="bibr" rid="scirp.48142-ref6">6</xref>] . This basal level of autophagy may contribute to cell protection. On the other hand, autophagy was induced efficiently in each cell line after exposure to C-ion beams (<xref ref-type="fig" rid="fig3">Figure 3</xref>(c)). This result was supported by recent findings that C-ion beams can induce autophagy in various tumor cells ef- fectively, and that the autophagy level in irradiated cells increased in a dose- and LET-dependent manner [<xref ref-type="bibr" rid="scirp.48142-ref37">37</xref>] . These results suggest that hyperinduced apoptosis and autophagy are associated with C-ion beam-induced cell death in SAS-R cells.</p><p>These results indicate that C-ion beams induce poly-caspase activity (<xref ref-type="fig" rid="fig4">Figure 4</xref>(a)) and suppress AKT signal- ing (<xref ref-type="fig" rid="fig4">Figure 4</xref>(b) and <xref ref-type="fig" rid="fig4">Figure 4</xref>(c)) and, and this concurs well with previous findings [<xref ref-type="bibr" rid="scirp.48142-ref21">21</xref>] . Recently, it was also reported that the ability of C-ion beams to inhibit the activation of the AKT pathway increased with increasing LET values [<xref ref-type="bibr" rid="scirp.48142-ref37">37</xref>] . AKT signaling can also block cell death signaling pathways by regulating various target mo- lecules such as apoptosis related proteins [<xref ref-type="bibr" rid="scirp.48142-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.48142-ref39">39</xref>] .</p><p>C-ion beams may simultaneously kill both non-CSCs and CSCs; consequently, the cell population of CSCs was only slightly increased or unchanged (<xref ref-type="fig" rid="fig5">Figure 5</xref>). If CSCs were eliminated, a cancer would be unable to grow and unable to spread to other locations in the body. Recently, it was reported that C-ion beams targeted cancer stem-like cells in the colon and pancreas [<xref ref-type="bibr" rid="scirp.48142-ref40">40</xref>] [<xref ref-type="bibr" rid="scirp.48142-ref41">41</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>These results suggest that C-ion beams may enhance apoptosis and autophagy through the activation of death signaling, and may target CSCs via the depression of AKT survival signaling in X-ray resistant cancer cells. Therefore, the concept of a C-ion augmentation therapy delivered to recurrent patients with clinically radio-re- sistant cells after conventional RT might offer a promising treatment alternative or supplement. More detailed studies are necessary to define the initial events which occur during the depression of AKT survival signaling after exposure to C-ion beams.</p></sec><sec id="s6"><title>Acknowledgements</title><p>This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Tech- nology of Japan (MEXT) and the Program to Disseminate the Tenure Tracking System of MEXT granted to Gunma University. The study was performed as part of the Research Project with heavy ions at the Gunma University Heavy Ion Medical Center (GHMC, Gunma University).</p></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.48142-ref1"><label>1</label><mixed-citation publication-type="book" xlink:type="simple">Joiner, M.C., van der Kogel, A.J. and Steel, G.G. (2009) Introduction: The Significance of Radiobiology and Radiotherapy for Cancer Treatment. In: Joiner, M. and van der Kogel, A., Eds., Basic Clinical Radiobiology Fourth Edition, Hodder Arnold Publication, London, 1-10. http://dx.doi.org/10.1201/b13224-2</mixed-citation></ref><ref id="scirp.48142-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kim, J.J. and Tannock, I.F. (2005) Repopulation of Cancer Cells during Therapy: An Important Cause of Treatment Failure. Nature Reviews Cancer, 5, 516-525.</mixed-citation></ref><ref id="scirp.48142-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Kuwahara, Y., Li, L., Baba, T., Nakagawa, H., Shimura, T., Yamamoto, Y., Ohkubo, Y. and Fukumoto, M. (2009) Clinically Relevant Radioresistant Cells Efficiently Repair DNA Double-Strand Breaks Induced by X-Rays. Cancer Science, 100, 747-752.</mixed-citation></ref><ref id="scirp.48142-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kuwahara, Y., Mori, M., Oikawa, T., Shimura, T., Ohtake, Y., Mori, S., Ohkubo, Y. and Fukumoto, M. (2010) The Modified High-Density Survival Assay Is the Useful Tool to Predict the Effectiveness of Fractionated Radiation Exposure. Journal of Radiation Research, 51, 297-302. http://dx.doi.org/10.1269/jrr.09094</mixed-citation></ref><ref id="scirp.48142-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Shimura, T., Kakuda, S., Ochiai, Y., Nakagawa, H., Kuwahara, Y., Takai, Y., Kobayashi, J., Komatsu, K. and Fukumoto, M. (2010) Acquired Radioresistance of Human Tumor Cells by DNA-PK/AKT/GSK3 Beta-Mediated Cyclin D1 Overexpression. Oncogene, 29, 4826-4837.</mixed-citation></ref><ref id="scirp.48142-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Kuwahara, Y., Oikawa, T., Ochiai, Y., Roudkenar, M.H., Fukumoto, M., Shimura, T., Ohtake, Y., Ohkubo, Y., Mori, S., Uchiyama, Y. and Fukumoto, M. (2011) Enhancement of Autophagy Is a Potential Modality for Tumors Refractory to Radiotherapy. Cell Death and Disease, 30, e177.</mixed-citation></ref><ref id="scirp.48142-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Shimura, T., Noma, N., Oikawa, T., Ochiai, Y., Kakuda, S., Kuwahara, Y., Takai, Y., Takahashi, A. and Fukumoto, M. (2012) Activation of the AKT/Cyclin D1/Cdk4 Survival Signaling Pathway in Radioresistant Cancer Stem Cells. Oncogenesis, 1, e12.</mixed-citation></ref><ref id="scirp.48142-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Shimura, T., Ochiai, Y., Noma, N., Oikawa, T., Sano, Y. and Fukumoto, M. (2013) Cyclin D1 Overexpression Perturbs DNA Replication and Induces Replication-Associated DNA Double-Strand Breaks in Acquired Radioresistant Cells. Cell Cycle, 12, 773-782.</mixed-citation></ref><ref id="scirp.48142-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Kuwahara, Y., Mori, M., Kitahara, S., Fukumoto, M., Ezaki, T., Mori, S., Echigo, S., Ohkubo, Y. and Fukumoto, M. (2014) Targeting of Tumor Endothelial Cells Combining 2 Gy/Day of X-Ray with Everolimus Is the Effective Modality for Overcoming Clinically Relevant Radioresistant Tumors. Cancer Medicine, 3, 310-321.</mixed-citation></ref><ref id="scirp.48142-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Moretti, L., Cha, Y.I., Niermann, K.J. and Lu, B. (2007) Switch between Apoptosis and Autophagy: Radiation-Induced Endoplasmic Reticulum Stress? Cell Cycle, 6, 793-798. http://dx.doi.org/10.4161/cc.6.7.4036</mixed-citation></ref><ref id="scirp.48142-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E.S., Baehrecke, E.H., Blagosklonny, M.V., El-Deiry, W.S., Golstein, P., Green, D.R., Hengartner, M., Knight, R.A., Kumar, S., Lipton, S.A., Malorni, W., Nu&amp;#241ez, G., Peter, M.E., Tschopp, J., Yuan, J., Piacentini, M., Zhivotovsky, B. and Melino, G. (2009) Classification of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death and Differentiation, 16, 3-11.</mixed-citation></ref><ref id="scirp.48142-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Chang, L., Graham, P.H., Hao, J., Ni, J., Bucci, J., Cozzi, P.J., Kearsley, J.H. and Li, Y. (2013) Acquisition of Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotypes Is Associated with Activation of the PI3K/ Akt/mTOR Pathway in Prostate Cancer Radioresistance. Cell Death and Disease, 4, e875.</mixed-citation></ref><ref id="scirp.48142-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Pardal, R., Clarke, M.F. and Morrison, S.J. (2003) Applying the Principles of Stem-Cell Biology to Cancer. Nature Reviews Cancer, 3, 895-902.</mixed-citation></ref><ref id="scirp.48142-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Bao, S., Wu, Q., McLendon, R.E., Hao, Y., Shi, Q., Hjelmeland, A.B., Dewhirst, M.W., Bigner, D.D. and Rich, J.N. (2006) Glioma Stem Cells Promote Radioresistance by Preferential Activation of the DNA Damage Response. Nature, 444, 756-760.</mixed-citation></ref><ref id="scirp.48142-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Baumann, M., Krause, M. and Hill, R. (2008) Exploring the Role of Cancer Stem Cells in Radioresistance. Nature Reviews Cancer, 8, 545-554.</mixed-citation></ref><ref id="scirp.48142-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Nguyen, G.H., Murph, M.M. and Chang, J.Y. (2011) Cancer Stem Cell Radioresistance and Enrichment: Where Frontline Radiation Therapy May Fail in Lung and Esophageal Cancers. Cancers, 3, 1232-1252.http://dx.doi.org/10.3390/cancers3011232</mixed-citation></ref><ref id="scirp.48142-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Kanai, T., Furusawa, Y., Fukutsu, K., Itsukaichi, H., Eguchi-Kasai, K. and Ohara, H. (1997) Irradiation of Mixed Beam and Design of Spread-Out Bragg Peak for Heavy-Ion Radiotherapy. Radiation Research, 147, 78-85.http://dx.doi.org/10.2307/3579446</mixed-citation></ref><ref id="scirp.48142-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Tsujii, H. and Kamada, T. (2007) A Review of Update Clinical Results of Carbon Ion Radiotherapy. Japanese Journal of Clinical Oncology, 42, 670-685. http://dx.doi.org/10.1093/jjco/hys104</mixed-citation></ref><ref id="scirp.48142-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Durante, M. and Loeffler, J.S. (2010) Charged Particles in Radiation Oncology. Nature Reviews Clinical Oncology, 7, 37-43. http://dx.doi.10.1038/nrclinonc. 2009.183</mixed-citation></ref><ref id="scirp.48142-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Ohno, T. (2013) Particle Radiotherapy with Carbon Ion Beams. The EPMA Journal, 4, 9. http://dx.doi.org/10.1186/1878-5085-4-9</mixed-citation></ref><ref id="scirp.48142-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Nakagawa, Y., Takahashi, A., Kajihara, A., Yamakawa, N., Imai, Y., Ota, I., Okamoto, N., Mori, E., Noda, T., Furusawa, Y., Kirita, T. and Ohnishi, T. (2012) Depression of p53-Independent Akt Survival Signals in Human Oral Cancer Cells Bearing Mutated p53 Gene after Exposure to High-LET Radiation. Biochemical and Biophysical Research Communications, 423, 654-660. http://dx.doi.org/10.1016/j.bbrc.2012.06.004</mixed-citation></ref><ref id="scirp.48142-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ohno, T., Kanai, T., Yamada, S., Yusa, K., Tashiro, M., Shimada, H., Torikai, K., Yoshida, Y., Kitada, Y., Katoh, H., Ishii, T. and Nakano, T. (2011) Carbon Ion Radiotherapy at the Gunma University Heavy Ion Medical Center: New Facility Set-Up. Cancers, 3, 4046-4060. http://dx.doi.org/10.3390/cancers3044046</mixed-citation></ref><ref id="scirp.48142-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Mirzayans, R., Andrais, B., Scott, A., Tessier, A. and Murray, D. (2007) A Sensitive Assay for the Evaluation of Cytotoxicity and Its Pharmacologic Modulation in Human Solid Tumor-Derived Cell Lines Exposed to Cancer-Therapeutic Agents. Journal of Pharmacy and Pharmaceutical Sciences, 10, 298s-311s.</mixed-citation></ref><ref id="scirp.48142-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Han, J., Fujisawa, T., Husain, S.R. and Puri, R.K. (2014) Identification and Characterization of Cancer Stem Cells in Human Head and Neck Squamous Cell Carcinoma. BMC Cancer, 14, 173.http://dx.doi.org/10.1186/1471-2407-14-173</mixed-citation></ref><ref id="scirp.48142-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Waldron, N.N., Barsky, S.H., Dougherty, P.R. and Vallera, D.A. (2014) A Bispecific EpCAM/CD133-Targeted Toxin Is Effective against Carcinoma. Targeted Oncology, in press.</mixed-citation></ref><ref id="scirp.48142-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Ando, K. and Kase, Y. (2009) Biological Characteristics of Carbon-Ion Therapy. International Journal of Radiation Biology, 85, 715-728. http://dx.doi.org/10.1080/09553000903072470</mixed-citation></ref><ref id="scirp.48142-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Suzuki, M., Kase, Y., Yamaguchi, H., Kanai, T. and Ando, K. (2000) Relative Biological Effectiveness for Cell-Killing Effect on Various Human Cell Lines Irradiated with Heavy-Ion Medical Accelerator in Chiba (HIMAC) Carbon-Ion Beams. International Journal of Radiation Oncology, Biology, Physics, 48, 241-250. http://dx.doi.org/10.1016/S0360-3016(00)00568-X</mixed-citation></ref><ref id="scirp.48142-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Hirayama, R., Furusawa, Y., Fukawa, T. and Ando, K. (2005) Repair Kinetics of DNA-DSB Induced by X-Rays or Carbon Ions under Oxic and Hypoxic Conditions. Journal of Radiation Research, 46, 325-332. http://dx.doi.org/10.1269/jrr.46.325</mixed-citation></ref><ref id="scirp.48142-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Takahashi, A., Yamakawa, N., Kirita, T., Omori, K., Ishioka, N., Furusawa, Y., Mori, E., Ohnishi, K. and Ohnishi, T. (2008) DNA Damage Recognition Proteins Localize along Heavy Ion Induced Tracks in the Cell Nucleus. Journal of Radiation Research, 49, 645-652. http://dx.doi.org/10.1269/jrr.08007</mixed-citation></ref><ref id="scirp.48142-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Akino, Y., Teshima, T., Kihara, A., Kodera-Suzumoto, Y., Inaoka, M., Higashiyama, S., Furusawa, Y. and Matsuura, N. (2009) Carbon-Ion Beam Irradiation Effectively Suppresses Migration and Invasion of Human Non-Small-Cell Lung Cancer Cells. International Journal of Radiation Oncology, Biology, Physics, 75, 475-481. http://dx.doi.org/10.1016/j.ijrobp.2008.12.090</mixed-citation></ref><ref id="scirp.48142-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Takahashi, A., Ohnishi, K., Ota, I., Asakawa, I., Tamamoto, T., Furusawa, Y., Matsumoto, H. and Ohnishi, T. (2001) p53-Dependent Thermal Enhancement of Cellular Sensitivity in Human Squamous Cell Carcinomas in Relation to LET. International Journal of Radiation Biology, 77, 1043-1051. http://dx.doi.org/10.1080/09553000110066095</mixed-citation></ref><ref id="scirp.48142-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Takahashi, A., Matsumoto, H., Yuki, K., Yasumoto, J., Kajihara, A., Aoki, M., Furusawa, Y., Ohnishi, K. and Ohnishi, T. (2004) High-LET Radiation Enhanced Apoptosis But Not Necrosis Regardless of p53 Status. International Journal of Radiation Oncology, Biology, Physics, 60, 591-597. http://dx.doi.org/10.1016/j.ijrobp.2004.05.062</mixed-citation></ref><ref id="scirp.48142-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Takahashi, A., Matsumoto, H., Furusawa, Y., Ohnishi, K., Ishioka, N. and Ohnishi, T. (2005) Apoptosis Induced by High-LET Radiations Is Not Affected by Cellular p53 Gene Status. International Journal of Radiation Biology, 81, 581-586. http://dx.doi.org/10.1080/09553000500280484</mixed-citation></ref><ref id="scirp.48142-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Vakifahmetoglu, H., Olsson, M. and Zhivotovsky, B. (2008) Death through a Tragedy: Mitotic Catastrophe. Cell Death and Differentiation, 15, 1153-1162. http://dx.doi.org/10.1038/cdd.2008.47</mixed-citation></ref><ref id="scirp.48142-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Vitale, I., Galluzzi, L., Castedo, M. and Kroemer, G. (2011) Mitotic Catastrophe: A Mechanism for Avoiding Genomic Instability. Nature Reviews Molecular Cell Biology, 12, 385-392. http://dx.doi.org/10.1038/nrm3115</mixed-citation></ref><ref id="scirp.48142-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Shintani, T. and Klionsky, D.J. (2004) Autophagy in Health and Disease: A Double-Edged Sword. Science, 306, 990-995. http://dx.doi.org/10.1126/science.1099993</mixed-citation></ref><ref id="scirp.48142-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Jin, X., Liu, Y., Ye, F., Liu, X., Furusawa, Y., Wu, Q., Li, F., Zheng, X., Dai, Z. and Li, Q. (2014) Role of Autophagy in High Linear Energy Transfer Radiation-Induced Cytotoxicity to Tumor Cells. Cancer Science, 105, 770-778.http://dx.doi.org/10.1111/cas.12422</mixed-citation></ref><ref id="scirp.48142-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Nicholson, K.M. and Anderson, N.G. (2002) The Protein Kinase B/Akt Signalling Pathway in Human Malignancy. Cell Signaling, 14, 381-395. http://dx.doi.org/10.1016/S0898-6568(01)00271-6</mixed-citation></ref><ref id="scirp.48142-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Duronio, V. (2008) The Life of a Cell: Apoptosis Regulation by the PI3K/PKB Pathway. The Biochemical Journal, 415, 333-344. http://dx.doi.org/10.1042/BJ20081056</mixed-citation></ref><ref id="scirp.48142-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Cui, X., Oonishi, K., Tsujii, H., Yasuda, T., Matsumoto, Y., Furusawa, Y., Akashi, M., Kamada, T. and Okayasu, R. (2011) Effects of Carbon Ion Beam on Putative Colon Cancer Stem Cells and Its Comparison with X-Rays. Cancer Research, 71, 3676-3687. http://dx.doi.org/10.1158/0008-5472.CAN-10-2926</mixed-citation></ref><ref id="scirp.48142-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Oonishi, K., Cui, X., Hirakawa, H., Fujimori, A., Kamijo, T., Yamada, S., Yokosuka, O. and Kamada, T. (2012) Different Effects of Carbon Ion Beams and X-Rays on Clonogenic Survival and DNA Repair in Human Pancreatic Cancer Stem-Like Cells. Radiotherapy and Oncology, 105, 258-265. http://dx.doi.org/10.1016/j.radonc.2012.08.009</mixed-citation></ref></ref-list></back></article>